ItalyThe article discusses the increasing popularity of weight-loss medications such as Semaglutide and Tirzepatide, which are primarily used to treat type 2 diabetes and clinically significant obesity. While these drugs have proven therapeutic benefits beyond just weight loss, there is growing concern over their misuse for purely aesthetic purposes. Experts warn against using them without proper medical diagnosis, emphasizing that they are chronic disease treatments, not shortcuts for beauty. The Italian market has seen a 34.9% increase in spending on anti-diabetic drugs in 2025, with private purchases of these medications rising significantly. This trend raises concerns about inappropriate usage and potential health risks.
Bias read (Center): The article presents expert warnings and statistical data without overtly favoring any side. It highlights both the medical benefits and the risks of misuse but does not take a clear stance on the issue, maintaining a balanced tone.
